News
The FDA granted de novo authorization to the first artificial intelligence (AI) program to support breast cancer risk ...
1d
MedPage Today on MSNPerioperative Durvalumab Plus FLOT Boosts EFS in Resectable Gastric/GEJ CancerCHICAGO -- Adding perioperative durvalumab (Imfinzi) to FLOT chemotherapy significantly improved event-free survival (EFS) ...
7h
News-Medical.Net on MSNGenome doubling identified as common event in metastatic cancer evolutionWhen cancer spreads from a primary tumor to new sites throughout the body, it undergoes changes that increase its genetic ...
Conquer Cancer®, the ASCO Foundation, presented the 2025 Young Investigator Awards (YIAs) funded by Vaniam Group™ and Women ...
Researchers from the Francis Crick Institute, UCL, Gustave Roussy and Memorial Sloan Kettering Cancer Center (MSK), have ...
A clinical trial at MSK found that music therapy for cancer-related anxiety is as effective as cognitive behavioral therapy and produces long-lasting benefits. Dr. Kevin Liou presented the results of ...
AstraZeneca’s immunotherapy Imfinzi has proven it can help certain patients with early-stage stomach cancer, according to ...
3d
News-Medical.Net on MSNNew insights into decades-old bladder cancer treatment offers clues for immunotherapyMore than three decades ago, the U.S. Food and Drug Administration (FDA) approved Bacillus Calmette-Guérin (BCG) as the first ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results